Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer
- PMID: 19099586
- PMCID: PMC2631013
- DOI: 10.1186/1471-2407-8-381
Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer
Abstract
Background: Enhanced activity of histone deacetylases (HDAC) is associated with more aggressive tumour behaviour and tumour progression in various solid tumours. The over-expression of these proteins and their known functions in malignant neoplasms has led to the development of HDAC inhibitors (HDI) as new anti-neoplastic drugs. However, little is known about HDAC expression in renal cell cancer.
Methods: We investigated the expression of HDAC 1, 2 and 3 in 106 renal cell carcinomas and corresponding normal renal tissue by immunohistochemistry on tissue micro arrays and correlated expression data with clinico-pathological parameters including patient survival.
Results: Almost 60% of renal cell carcinomas expressed the HDAC isoforms 1 and 2. In contrast, HDAC 3 was only detected in 13% of all renal tumours, with particular low expression rates in the clear cell subtype. HDAC 3 was significantly higher expressed in pT1/2 tumours in comparison to pT3/4 tumours. Expression of class I HDAC isoforms correlated with each other and with the proliferative activity of the tumours. We found no prognostic value of the expression of any of the HDAC isoforms in this tumour entity.
Conclusion: Class I HDAC isoforms 1 and 2 are highly expressed in renal cell cancer, while HDAC 3 shows low, histology dependent expression rates. These unexpected differences in the expression patterns suggests alternative regulatory mechanisms of class I HDACs in renal cell cancer and should be taken into account when trials with isoform selective HDI are being planned. Whether HDAC expression in renal cancers is predictive of responsiveness for HDI will have to be tested in further studies.
Figures




Similar articles
-
Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy.Br J Cancer. 2008 Feb 12;98(3):604-10. doi: 10.1038/sj.bjc.6604199. Epub 2008 Jan 22. Br J Cancer. 2008. PMID: 18212746 Free PMC article.
-
Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis.Lancet Oncol. 2008 Feb;9(2):139-48. doi: 10.1016/S1470-2045(08)70004-4. Lancet Oncol. 2008. PMID: 18207460
-
HDAC 1 and 6 modulate cell invasion and migration in clear cell renal cell carcinoma.BMC Cancer. 2016 Aug 9;16:617. doi: 10.1186/s12885-016-2604-7. BMC Cancer. 2016. PMID: 27506904 Free PMC article.
-
HDAC expression and clinical prognosis in human malignancies.Cancer Lett. 2009 Aug 8;280(2):168-76. doi: 10.1016/j.canlet.2008.10.047. Epub 2008 Dec 21. Cancer Lett. 2009. PMID: 19103471 Review.
-
Explorative study on isoform-selective histone deacetylase inhibitors.Chem Pharm Bull (Tokyo). 2009 Sep;57(9):897-906. doi: 10.1248/cpb.57.897. Chem Pharm Bull (Tokyo). 2009. PMID: 19721249 Review.
Cited by
-
Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications.MedComm (2020). 2023 May 2;4(3):e261. doi: 10.1002/mco2.261. eCollection 2023 Jun. MedComm (2020). 2023. PMID: 37143582 Free PMC article. Review.
-
HDAC1 and HDAC2 independently predict mortality in hepatocellular carcinoma by a competing risk regression model in a Southeast Asian population.Oncol Rep. 2015 Nov;34(5):2238-50. doi: 10.3892/or.2015.4263. Epub 2015 Sep 9. Oncol Rep. 2015. PMID: 26352599 Free PMC article.
-
The epigenetic landscape of clear-cell renal cell carcinoma.J Kidney Cancer VHL. 2015 May 28;2(3):90-104. doi: 10.15586/jkcvhl.2015.33. eCollection 2015. J Kidney Cancer VHL. 2015. PMID: 28326264 Free PMC article.
-
Treatment of Refractory Metastatic Renal Cell Carcinoma.Cancers (Basel). 2022 Oct 13;14(20):5005. doi: 10.3390/cancers14205005. Cancers (Basel). 2022. PMID: 36291789 Free PMC article. Review.
-
The Functional Analysis of Histone Acetyltransferase MOF in Tumorigenesis.Int J Mol Sci. 2016 Jan 14;17(1):99. doi: 10.3390/ijms17010099. Int J Mol Sci. 2016. PMID: 26784169 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous